Bio-waiver for Pregabalin Capsules [Dissolution / BCS / IVIVC]

posted by luvblooms  – India, 2015-03-13 10:18 (3771 d 18:05 ago) – Posting: # 14563
Views: 12,617

Dear Samaya

❝ In my opinion, Literature reference for permeability in terms of caco 2 cell permeability values should be acceptable to FDA.

❝ If this value is not directly available, you can define high permeability using absolute bioavailability, rapid and complete absorption after oral administartion, mass balance data / % of unchanged drug recovered, wide therapeutic window for said drug.


In few cases FDA has not at all accepted the published literature information (even the Clinical Pharmacology and biopharmaceutics data of Inovator) so one need to be very cautious about that.
Also if the product/molecule is highly variable, FDA will ask you to do a BE study.

But in general for Pregabalin, these shall not be the concern!!

Hope this will help.

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,687 registered users;
45 visitors (0 registered, 45 guests [including 14 identified bots]).
Forum time: 05:23 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5